SPIEGELMAN DANIEL K sold MYGN
June 4, 2024 · Form 4 insider transaction
SPIEGELMAN DANIEL K sold 3,788 shares of Myriad Genetics, Inc. at $22.05 per share, a transaction worth $83.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,788
Price
$22.05
Total value
$83.5K
InsiderSPIEGELMAN DANIEL K
RoleDirector
CompanyMyriad Genetics, Inc. (MYGN)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 4, 2024
Filing dateJune 4, 2024
Shares owned after32,917
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.